Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CuraScript is a specialty pharmacy and distribution company that provides comprehensive services for patients with complex, chronic, and rare health conditions. As a subsidiary of Evernorth, a Cigna company, it manages the distribution and clinical support for high-cost specialty medications, including biologics and orphan drugs. The company operates through two primary segments: CuraScript Specialty Pharmacy, which provides direct-to-patient medication management, and CuraScript SD, which handles specialty distribution to healthcare providers. Their service model includes patient care coordination, financial assistance navigation, and clinical monitoring to ensure therapy adherence. CuraScript supports a wide range of therapeutic areas, including oncology, immunology, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CuraScript Pharmacy.